Fingerprint
Dive into the research topics of 'A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
Hagop M. Kantarjian, Michael W. Schuster, Nitin Jain, Anjali Advani, Elias Jabbour, Erick Gamelin, Erik Rasmussen, Gloria Juan, Abraham Anderson, Vincent F. Chow, Gregory Friberg, Florian D. Vogl, Mikkael A. Sekeres
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations